Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (31) , 32813-32823
- https://doi.org/10.1074/jbc.m313656200
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- MAP kinase kinase kinase, MAP kinase kinase and MAP kinasePublished by Elsevier ,2004
- Mutations of the BRAF gene in human cancerNature, 2002
- Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaJournal of Clinical Investigation, 2001
- Constitutive Activation of Extracellular Signal-Regulated Kinase in Human Acute Leukemias: Combined Role of Activation of MEK, Hyperexpression of Extracellular Signal-Regulated Kinase, and Downregulation of a Phosphatase, PAC1Blood, 1999
- Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumorsOncogene, 1999
- Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cellsLeukemia, 1997
- Hyperexpression of mitogen-activated protein kinase in human breast cancer.Journal of Clinical Investigation, 1997
- Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cellsCell, 1994
- Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factorBiochemical Journal, 1992
- PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activityNeuron, 1992